| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 9.880 | 29.529 | 24.508 | 23.845 | 26.783 | 28.015 | 27.382 | 52.944 |
| Total Income - EUR | - | 0 | 9.880 | 29.529 | 24.508 | 23.845 | 26.783 | 28.015 | 27.382 | 52.944 |
| Total Expenses - EUR | - | 0 | 31 | 183 | 2.555 | 493 | 2.214 | 2.832 | 12.807 | 18.469 |
| Gross Profit/Loss - EUR | - | 0 | 9.849 | 29.346 | 21.953 | 23.351 | 24.569 | 25.183 | 14.575 | 34.475 |
| Net Profit/Loss - EUR | - | 0 | 9.553 | 28.460 | 21.218 | 22.686 | 23.781 | 24.443 | 12.506 | 32.918 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Annanăstase Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 5.450 | 5.096 | 5.598 | 3.548 |
| Current Assets | - | 45 | 10.299 | 38.265 | 60.608 | 81.530 | 62.201 | 86.602 | 98.732 | 91.008 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 48 | 3.657 | 12.271 | 14.897 | 4.453 | 7.010 | 3.382 | 4.017 |
| Cash | - | 45 | 10.251 | 34.607 | 48.337 | 66.633 | 57.748 | 79.592 | 95.350 | 86.991 |
| Shareholders Funds | - | 45 | 9.597 | 37.881 | 58.365 | 79.944 | 67.047 | 91.699 | 103.926 | 92.561 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 0 | 142 | 384 | 2.243 | 2.206 | 604 | 0 | 404 | 1.996 |
| Income in Advance | - | 0 | 560 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Annanăstase Medical Srl